Biocon Agrees Biosimilar Partnership With Evotec
The Two Firms Have Signed A Licensing Deal
Biocon and Evotec have struck a licensing deal that will allow Biocon to expand its current basket of biosimilars beyond diabetes, oncology and immunology, in exchange for licensing and milestone payments to Evotec.
